Cargando…
Retracted: Novel lncRNA AL033381.2 Promotes Hepatocellular Carcinoma Progression by Upregulating PRKRA Expression
Autor principal: | Longevity, Oxidative Medicine and Cellular |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551345/ https://www.ncbi.nlm.nih.gov/pubmed/37810563 http://dx.doi.org/10.1155/2023/9894384 |
Ejemplares similares
-
Novel lncRNA AL033381.2 Promotes Hepatocellular Carcinoma Progression by Upregulating PRKRA Expression
por: Wang, Feiran, et al.
Publicado: (2022) -
Retracted: Novel Therapeutic Mechanism of Adipose-Derived Mesenchymal Stem Cells in Osteoarthritis via Upregulation of BTG2
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023) -
Retracted: Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023) -
Retracted: Recurrence of Early Hepatocellular Carcinoma after Surgery May Be Related to Intestinal Oxidative Stress and the Development of a Predictive Model
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023) -
Retracted: CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023)